8
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Fibronectin fragments cause an underestimation of plasma fibronectin levels in severe pre-eclampsia

, , , &
Pages 351-358 | Received 28 Nov 1995, Accepted 20 Feb 1996, Published online: 08 Jul 2009

References

  • Rodgers G M, Taylor R N, Roberts J M. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988; 159: 908–14
  • Eriksen H O, Hansen P K, Brocks V, Jensen B A. Plasma fibronectin concentration in normal pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand 1987; 66: 25–8
  • Hess L W, O'Brien W F, Holmberg J A, Winkel C A, Monghan W, Hemming V G. Plasma and amnotic fluid concentrations of fibronectin during normal pregnancy. Obstet Gynecol 1986; 68: 25–8
  • Brubaker D B, Ross M G, Marinoff D. The function of elevated plasma fibronectin in preeclampsia. Am J Obstet Gynecol 1992; 166: 526–31
  • Taylor R N, Varma M, Teng N NH, Stubbs T M, Lazarchick J, Horger E O. Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am J Obstet Gynecol 1984; 150: 885–7
  • Lazarchick J, Stubbs T M, Romein L, Van Dorsten, Loadholt C B. Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. Am J Obstet Gynecol 1986; 154: 1050–2
  • Taylor R N, Casal D C, Jones L A, Varma M, Martin J N, Roberts J M. Selective effects of preeclamptic sera on human endothelial cell procoagulant protein expression. Am J Obstet Gynecol 1991; 165: 1705–10
  • Saleh A A, Bottoms S F, Monem Farag A, Dombrowski M P, Welch R A, Norman G, et al. Markers for endothelial injury, clotting and platelet activation in preeclampsia. Arch Gynecol Obstet 1992; 251(3)105–110
  • Lockwood C J, Peters J H. Increased plasma levels of ED1 cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol 1990; 162: 358–62
  • Calvin S, Weinstein L, Witte H W, Finlay P R. Plasma levels of fibronectin and prostacyclin metabolites in peripartum preeclamptic women. Am J Perinatol 1990; 7(2)125–9
  • de Jager C A, Robson S C, Kirsch R E, Jacobs P, Harvest C, Dunne T, et al. Serial measurements of circulating tissue plasminogen activator and fibrin (ogen) degradation products predict outcome in gestational proteinuric hypertension. S Afr Med J 1993; 83(12)898–9
  • Selmer J, Eriksen H, Clemmensen I. Native and degraded fibronectin: new immunological methods for distinction. Scand J Clin Invest 1984; 44: 57–63
  • Bykowska K, Wegrzynowicz Z, Lopaciuk S, Kopec M. Effect of proteolysis on quantitation of plasma fibronectin concentration by two immunoassays (electroimmunoassay and immunoturbidimetric technique). Thromb Haemost 1985; 53(3)377–80
  • de Jager C A, Shephard E G, Robson S C, Jaskiewicz K, Froese S, Anthony J, et al. Degradation of fibronectin in association with vascular endothelial disruption in preeclampsia. J Lab Clin Med 1995; 125: 522–30
  • Brown R A. Failure of fibronectin as an opsonin in the host defence system: a case of competitive self-inhibition?. Lancet 1983; 1058–60
  • Davey D A, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892–8
  • Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5
  • Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4
  • Vuento M, Vaheri A. Purification of fibronectin from human plasma by affiity chromatography under non-denaturing conditions. Biochem J 1979; 183: 331–7
  • Check I, Wolfman H C, Coley T B, Hunter R E. Agglutination assay for human opsonic factor using gelatin-coated latex particles. J Retic Soc 1979; 25(4)351–62
  • Methods in immunology and immunochemistry, C A Williams, M W Chase. Academic Press, New York 1967; Vol 1: 158
  • Roberts J M, Taylor R N, Goldfien A. Endothelial cell activation as a pathogenetic factor in preec-lampsia. Semin Perinatol 1991; 15(1)86–93
  • Blashke E, Eklund A, Hembrand R. Determination of fibronectin and its degradation products in bronchoalveolar lavage fluid. Scand J Clin Lab Invest 1990; 50: 619–26
  • Erlich M I, Knishell J S, Blumenstock F A, Kaplan J E. Depression of phagocytosis by plasmin degradation products of plasma fibronectin. J Lab Clin Med 1981; 98: 263–71
  • Czop J K, Kadish J L, Austen K F. Augmentation of human monocyte opsonin-independent phagocytosis by fragments of human plasma fibronectin. Roc Natl Acad Sci USA 1981; 78(6)3649–53
  • Weiner C P. The mechanism of reduced antithrom-bin III activity in women with preeclampsia. Obstet Gynecol 1988; 72: 847–9
  • Yoshimura T, Yamashita J, Ito M, Matsui K, Maeyama M. Placental plasminogen activator activity in pre-eclampsia. Int J Gynaecol Obstet 1985; 23: 311–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.